Reinforcing the importance of iron in the underlying neuropathogenic changes of PD, the use of iron chelators in models of nigral neurodegeneration induced by proteasome inhibitors showed a decreased loss of dopaminergic neurons as well as a decreased α-synuclein aggregation and a consequential reduced formation of Lewy bodies [54, 66]. This evidence concerns the gene SNCA and Parkinson disease.